Benchmark Method for Cost Computations Across Health Care Systems: Cost of Care per Patient per Day in Breast Cancer Care
- 1 October 2021
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 17 (10) , e1403-e1412
Abstract
PURPOSE: To estimate the value of cancer care and to compare value among episodes of care, a transparent, reproducible, and standardized cost computation methodology is needed. Charges, claims, and reimbursements are related to cost but are nontransparent and proprietary. We developed a method to measure the cost of the following phases of care: (1) initial treatment with curative intent, (2) surveillance and survivorship care, and (3) relapse and end-of-life care. METHODS: We combined clinical data from our electronic health record, the state cancer registry, and the Social Security Death Index. We analyzed the care of patients with breast cancer and mapped Common Procedural Terminology (CPT) codes to the corresponding cost conversion factor and date in the CMS Medicare fee schedule. To account for varying duration of episodes of care, we computed a cost of care per day (CCPD) for each patient. RESULTS: Median CCPD for initial treatment was $29.45 in US dollars (USD), the CCPD for surveillance and survivorship care was $2.45 USD, and the CCPD for relapse care was $13.80 USD. Among the three breast cancer types (hormone receptor-positive or human epidermal growth factor receptor 2 [HER2]-negative, HER2-positive, and triple-negative), there was no difference in CCPD. Relapsed patients in the most expensive surveillance CCPD group had significantly shorter survival. CONCLUSION: We developed a method to identify high-value oncology care—cost of care per patient per day (CCPD)—in episodes of initial, survivorship, and relapse care. The methodology can help identify positive deviants (who have developed best practices) delivering high-value care. Merging our data with claims data from third-party payers can increase the accuracy and validity of the CCPD.Keywords
This publication has 18 references indexed in Scilit:
- The Future Awakens: A Report on the 2016 Vizient Clinical Connections SummitAmerican Journal of Medical Quality, 2017
- Understanding the landscape and challenges of end-of-life measurement among comprehensive cancer centers.Journal of Clinical Oncology, 2017
- Detecting Unplanned Care From Clinician Notes in Electronic Health RecordsJournal of Oncology Practice, 2015
- Optum Labs: Building A Novel Node In The Learning Health Care SystemHealth Affairs, 2014
- Breast cancer treatment across health care systems: Linking electronic medical records and state registry data to enable outcomes researchCancer, 2013
- Regional Variation in Spending and Survival for Older Adults With Advanced CancerJNCI: Journal of the National Cancer Institute, 2013
- American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for OncologyJournal of Clinical Oncology, 2012
- What Is Value in Health Care?New England Journal of Medicine, 2010
- Partnering With Payers for Success: Quality Oncology Practice Initiative, Blue Cross Blue Shield of Michigan, and the Michigan Oncology Quality ConsortiumJournal of Oncology Practice, 2009
- Clinical experience with docetaxel for Chinese breast cancer patients: Hematological toxicity profilesBreast Cancer, 2006